Interventional

Led by Dr. Michael Cleman, Professor of Medicine and Director of the Cardiac Catheterization Laboratory, the Interventional Cardiology service provides state of the art facilities for a full spectrum of coronary, structural heart disease, peripheral interventions, and invasive diagnostic studies. 

Areas of interest including complex coronary angioplasty, structural heart disease including percutaneous aortic valve replacement (TAVR), and peripheral vascular disease, including one of the largest carotid programs in New England. The interventional cardiology faculty are involved in a wide range of trails evaluating novel therapeutic options including bioabsobable stents, transcatheter devices for aortic valve replacement and mitral repair, and drug-eluting balloon therapies for peripheral vascular disease and critical limb ischemia.

Visit our YaleMedicine.org website to learn more about the Interventional Cardiology Program

Yale Interventional Cardiology has a robust history in cardiovascular catheterization and intervention providing state of the art care for patients in the New England and New York Regions and currently serves as a national and international referral center for specialty percutaneous interventional procedures. The Yale Interventional team services Yale New Haven Hospital, the West Haven Veterans Affairs Medical Center, Greenwich Hospital, Lawrence and Memorial Hospital, and Backus Hospitals in the Connecticut community.

Yale Interventional cardiology is focused on global vascular patient care with specialists in complex coronary disease, structural heart disease, and peripheral vascular diseases. We both lead and participate in a variety of clinical trials to develop devices and techniques to manage unmet needs in interventional cardiovascular medicine. Our research team is engaged in clinical investigation locally and also has global reach via our investigational team, infrastructure, and core laboratories with Yale Cardiovascular Research Group (YCRG). We have developed international affiliations with University College London in the UK, and Clinica Cardiovid in Columbia, South America, which has provided synergies in clinical medicine, research, and education. In addition we are in the process of establishing a similar affiliation with the University of Athens Medical School. 

The overall goal of these programs is to provide a framework to enhance research and development by providing an infrastructure and network for “vertical device development”, e.g. bench to regulatory approval and patient care.

From the early history of interventional cardiology at Yale with among the world’s first applications of rotational atherectomy, coronary stents, and brachytherapy to the current era of advanced coronary revascularization, transcatheter valve repair and replacement, structural interventions, and global endovacular patient care, the interventional team is excited to live in a fun, innovative, and interesting time at Yale. 

Faculty

  • Joseph Brennan

    Associate Professor of Medicine (Cardiology); Firm Chief- Coronary Intensive Care Unit (CICU), Internal Medicine; Director, Interventional Cardiology Fellowship Program, Internal Medicine; Medical Director, Coronary Intensive Care Unit, Yale-New Haven Hospital, Yale Medicine; Director, Inpatient Cardiology Services, Yale Medicine

  • Henry Cabin

    Professor of Medicine (Cardiology); Associate Section Chief Cardiovascular Medicine, Internal Medicine; Medical Director Network Development, Yale Medicine; Medical Director YNHH Heart and Vascular Center

  • Jeptha Curtis

    Associate Professor of Medicine (Cardiology); Medical Director, Performance Improvement, Heart & Vascular Center; Senior Scientific Advisor, NCDR; Director, Registry Data Analytic Center, Center for Outcomes Research & Evaluation (CORE)

  • John Forrest

    Associate Professor of Medicine (Cardiovascular Medicine); Director of Interventional Cardiology; Director, Structural Heart Disease Program

  • Christopher Howes

    Assistant Professor of Medicine (Cardiology); Chief of Cardiology, Greenwich Hospital, Cardiovascular Medicine; Director of Cardiac Catheterization and Intervention, Greenwich Hospital, Cardiovascular Medicine; Attending Physician Yale New Haven Hopsital Cardiac Catheterization Lab., Cardiovascular Medicine

  • Carlos Mena-Hurtado

    Associate Professor of Medicine (Cardiology); Director Cardiac Catheterization Laboratories, Internal Medicine; Director Vascular Medicine Fellowship, Interventional Cardiology Program; Director CME, Section of Cardiology, Internal Medicine; Co-Director Limb Preservation Program, Yale New Haven Health System; Honorary Clinical Reader in Centre, Clinical Pharmacology in the William Harvey Research Institute; Medical Director Vascular Medicine - YNHH, Internal Medicine